Search Results

• • 67,394 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.

  1

  Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.

  Authors:Jingyou Yu, Lisa H. Tostanoski, Noe B. Mercado, Katherine McMahan, Jinyan Liu, Catherine Jacob-Dolan, et al.From:Nature (Vol. 596, Issue 7872) Peer-Reviewed

  Aug. 19, 20217,135 words Report 1590LThe emergence of SARS-CoV-2 variants that partially evade neutralizing antibodies poses a threat to the efficacy of current COVID-19 vaccines.sup.1,2. The Ad26.COV2.S vaccine expresses a stabilized spike protein from the...
• Select COVID-19 vaccine insights: The news beyond the headlines: Here is key intelligence on the recommended primary series, boosters, breakthrough infection, adverse events, special population vaccination, vaccine myths, and what the future might hold.

  2

  COVID-19 vaccine insights: The news beyond the headlines: Here is key intelligence on the recommended primary series, boosters, breakthrough infection, adverse events, special population vaccination, vaccine myths, and what the future might hold.

  Authors:John L. Kiley, Matthew J. Dolan, and Jessica ServeyFrom:Journal of Family Practice (Vol. 71, Issue 8) Peer-Reviewed

  Oct. 20225,564 words Report 1960LWorldwide and across many diseases, vaccines have been transformative in reducing mortality--an effect that has been sustained with vaccines that protect against COVID-19. (1) Since the first cases of SARS-CoV-2...
• Select Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

  3

  Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

  Authors:Noe B. Mercado, Roland Zahn, Frank Wegmann, Carolin Loos, Abishek Chandrashekar, Jingyou Yu, et al.From:Nature (Vol. 586, Issue 7830) Peer-Reviewed

  Oct. 22, 20209,222 words Report 1550LA safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic.sup.1-8. For global deployment and pandemic control, a...
• Select Drug-induced liver injury after covid-19 mRNA vaccine: case report/Dano hepatico inducido por farmacos despues de la vacuna RNAm PARA COVID-19: reporte de caso.

  4

  Drug-induced liver injury after covid-19 mRNA vaccine: case report/Dano hepatico inducido por farmacos despues de la vacuna RNAm PARA COVID-19: reporte de caso.

  Authors:Ayleen Rivera-Tenorio, Hector Hernandez Diaz, Pablo Andres Triana, Juliana Gutierrez-Posso, Ana Maria Osorio-Gomez, Julio Ernesto Saez Velandia, et al.From:Colombia Medica (Vol. 53, Issue 3) Peer-Reviewed

  July-Sep 20223,101 words Estudio de caso Case description: A 22-year-old female patient received the first dose of Pfizer-BioNTech vaccine (RNAm) against COVID-19; 6 days later, she presented abdominal pain located in the right hypochondrium and epigastrium,...
• Select COVID-19 vaccines--changing perspectives.

  5

  COVID-19 vaccines--changing perspectives.

  Author:Bridget FarhamFrom:SAMJ South African Medical Journal (Vol. 111, Issue 3) Peer-Reviewed

  Mar. 20211,033 words Editorial 1500L2020 changed our lives. For too many it was the end of their life. For all of us, it heralded a new reality. During 2020 my social media feed was full of people wishing the year would end. I thought that little would...
• Select ASDS issues guidance for safe use of dermal filler in relation to SARS-CoV-2 vaccine.

  6

  ASDS issues guidance for safe use of dermal filler in relation to SARS-CoV-2 vaccine.

  Author:Ted BosworthFrom:Dermatology News (Vol. 52, Issue 2)

  Feb. 2021732 words Article 1490LEvidence that a SARS-CoV-2 vaccine is associated with inflammatory reactions in patients with dermal fillers has led the American Society for Dermatologic Surgery to issue a guidance outlining the potential risk and...
• Select Scientists tackle vaccine safety, efficacy and access at global R&D forum

  7

  Scientists tackle vaccine safety, efficacy and access at global R&D forum

  From:Saudi Medical Journal (Vol. 42, Issue 2) Peer-Reviewed

  Feb. 2021461 words Conference news 1450L16 January 2021--More than 2,800 scientists from 130 countries gathered on Friday (January 15) in a virtual forum hosted by the World Health Organization (WHO) to identify knowledge gaps and set research priorities for...
• Select ACIP recommendations for COVID-19 vaccines--and more.

  8

  ACIP recommendations for COVID-19 vaccines--and more.

  Author:Doug Campos-OutcaltFrom:Journal of Family Practice (Vol. 70, Issue 2) Peer-Reviewed

  Mar. 20211,508 words Report 1550LPrioritized immunization is advised with the 2 COVID-19 vaccines. A third meningococcal ACWY vaccine is now the only one approved for those > 55 years. The year 2020 was challenging for public health agencies and...
• Select What should define a SARS-CoV-2 "breakthrough" infection?

  9

  What should define a SARS-CoV-2 "breakthrough" infection?

  Authors:John S. Schieffelin, Elizabeth B. Norton, and Jay K. KollsFrom:Journal of Clinical Investigation (Vol. 131, Issue 12) Peer-Reviewed

  June 15, 20211,353 words Article 1450LRecently, there have been several reports of SARS-CoV-2 "breakthrough" infections that have occurred in recipients of the FDA-approved SARS-CoV-2 vaccines (1). These reports have the potential to undermine public...
• Select COVID-19, Ebola virus disease and the community.

  10

  COVID-19, Ebola virus disease and the community.

  Author:Bridget FarhamFrom:SAMJ South African Medical Journal (Vol. 111, Issue 5) Peer-Reviewed

  May 20211,126 words Editorial 1550LThe Democratic Republic of the Congo (DRC) declared the end of its 10th Ebola virus disease (EVD) outbreak on 25 June 2020. The outbreak was declared in North Kivu on 1 August 2018, and by the time it ended there had...
• Select Effectiveness of BNT162b2 Vaccine in Adolescents During Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.

  11

  Effectiveness of BNT162b2 Vaccine in Adolescents During Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.

  Authors:Aharona Glatman-Freedman, Yael Hershkovitz, Zalman Kaufman, Rita Dichtiar, Lital Keinan-Boker, and Michal BrombergFrom:Emerging Infectious Diseases (Vol. 27, Issue 11) Peer-Reviewed

  Nov. 20211,950 words Report 1600LIn Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We...
• Select Pfizer COVID vaccine protects against worrying coronavirus variants.

  12

  Pfizer COVID vaccine protects against worrying coronavirus variants.

  Author:Ewen CallawayFrom:Nature (Vol. 593, Issue 7859) Peer-Reviewed

  May 20, 20211,070 words Article 1490LData from Qatar provide strongest evidence yet that COVID-19 vaccines can stop strains thought to pose a threat to immunization efforts. Data from Qatar provide strongest evidence yet that COVID-19 vaccines can stop...
• Select Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population.

  13

  Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population.

  Authors:Rachel E. Pollreis, Clay Roscoe, Rachel J. Phinney, Surabhi S. Malesha, Matthew C. Burns, Aimee Ceniseros, et al.From:PLoS ONE (Vol. 16, Issue 12) Peer-Reviewed

  Dec. 2, 20214,169 words Report 1540LSARS-CoV-2 RT-PCR, the gold standard for diagnostic testing, may not be readily available or logistically applicable for routine COVID-19 testing in many rural communities in the United States. In this validation study,...
• Select Coronavirus vaccines will save 2021? "Light at the end of the tunnel".

  14

  Coronavirus vaccines will save 2021? "Light at the end of the tunnel".

  Author:Ricardo Santos de OliveiraFrom:Archives of Pediatric Neurosurgery (Vol. 3, Issue 1) Peer-Reviewed

  Jan-April 2021359 words Article 1080LOn 11 March, the WHO confirmed coronavirus disease 2019 as a pandemic. The Director-General of the WHO called on governments to change its course by taking "urgent and aggressive action" (1). In terms of the number of...
• Select Healthcare Workers Should be Recieved with The Highest Effective Vaccine Available.

  15

  Healthcare Workers Should be Recieved with The Highest Effective Vaccine Available.

  Authors:Ozlem Kurt Azap, Hande Arslan, Cigdem Erol, Tugba Yanik Yalcin, and Nuran SariFrom:Infectious Diseases and Clinical Microbiology (Vol. 3, Issue 2) Peer-Reviewed

  Aug. 2021900 words Letter to the editor 1230LThe burden of COVID-19 on healthcare workers (HCWs) is increasing day by day, particularly in countries with high incidence. Turkey was the fourth leading country after India, the USA and Brazil that reported the highest...
• Select Acceptance of COVID-19 vaccination and its determinants among Lebanese dentists: a cross-sectional study.

  16

  Acceptance of COVID-19 vaccination and its determinants among Lebanese dentists: a cross-sectional study.

  Authors:Lara Nasr, Nadine Saleh, Mira Hleyhel, Abbass El-Outa, and Ziad NoujeimFrom:BMC Oral Health (Vol. 21, Issue 1) Peer-Reviewed

  Sept. 29, 20214,457 words Report 1610LBackground Dentists are at high risk of exposure to occupational Coronavirus Disease 2019 (COVID-19). Since vaccination is crucial to control COVID-19 pandemic, we aimed to assess COVID-19 vaccination acceptance and...
• Select Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.

  17

  Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.

  Authors:Ekaterina Krieger, Alexander Kudryavtsev, Ekaterina Sharashova, Vitaly Postoev, Natalia Belova, Leonid Shagrov, et al.From:Emerging Infectious Diseases (Vol. 28, Issue 2) Peer-Reviewed

  Feb. 20221,397 words Report 1310LPopulation-based data on coronavirus disease in Russia and on the immunogenicity of the Sputnik V vaccine are sparse. In a survey of 1,080 residents of Arkhangelsk 40-75 years of age, 65% were seropositive for IgG....
• Select Acceptance of COVID-19 vaccination during pregnancy among Thai pregnant women and their spouses: a prospective survey.

  18

  Acceptance of COVID-19 vaccination during pregnancy among Thai pregnant women and their spouses: a prospective survey.

  Authors:Kotchakorn Pairat and Chadakarn PhaloprakarnFrom:Reproductive Health (Vol. 19, Issue 1) Peer-Reviewed

  Mar. 24, 20224,027 words Report 1490LBackground Vaccination is one of the most reliable interventions against coronavirus disease 2019 (COVID-19). Although pregnant women's attitudes toward COVID-19 vaccination are well studied, husbands' views toward...
• Select Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Metis Peoples living in Toronto and London, Ontario.

  19

  Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Metis Peoples living in Toronto and London, Ontario.

  Authors:Janet Smylie, Stephanie McConkey, Beth Rachlis, Lisa Avery, Graham Mecredy, Raman Brar, et al.From:CMAJ: Canadian Medical Association Journal (Vol. 194, Issue 29) Peer-Reviewed

  Aug. 2, 20225,712 words Report 2030LBackground: First Nations, Inuit and Metis Peoples across geographies are at higher risk of SARS-CoV-2 infection and COVID-19 because of high rates of chronic disease, inadequate housing and barriers to accessing health...
• Select Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.

  20

  Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.

  Authors:Annalisa Fierro, Silvio Romano, and Antonella LiccardoFrom:PLoS ONE (Vol. 17, Issue 7) Peer-Reviewed

  July 8, 202211,300 words Report 1730LThe last year of Covid-19 pandemic has been characterized by the continuous chase between the vaccination campaign and the appearance of new variants that puts further obstacles to the possibility of eradicating the...